Devices for remote monitoring of Parkinson’s disease (HTG657)Product type:GuidanceProgramme:HealthTech guidanceLast updated: 25 January 2024Published: 25 January 2023
Foslevodopa–foscarbidopa for treating advanced Parkinson’s with motor symptoms (TA934)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 29 November 2023
Suspected neurological conditions: recognition and referral (NG127)Product type:GuidanceProgramme:NICE guidelineLast updated: 2 October 2023Published: 1 May 2019
Xeomin (botulinum neurotoxin type A) for treating chronic sialorrhoea (TA605)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 9 October 2019
Parkinson’s disease in adults (NG71)Product type:GuidanceProgramme:NICE guidelinePublished: 19 July 2017